Meetings & Events
The TaMADOR consortium holds regular meetings and symposia to share progress, discuss challenges, and engage with the broader diabetes and obesity research community.
Upcoming Meetings
2026 TaMADOR Spring Symposium
UW Medicine at South Lake Union, Brotman Auditorium (D Bldg), Seattle, WA
Targeted Mass Spectrometry Assays for Diabetes and Obesity Research symposium featuring presentations on proteomics, biomarker validation, proinsulin assays, and clinical applications in type 1 diabetes.
Past Meetings
2025 TaMADOR Meeting at NIH
National Institutes of Health, Bethesda, MD
Biomarkers and Mass Spectrometry–Based Assays in Type 1 Diabetes Clinical Research. Members of the TaMADOR consortium provided an overview of recent advances, with a special focus on type 1 diabetes.
Meeting Information | View Agenda“for Biomarkers and Mass Spectrometry–Based Assays in Type 1 Diabetes Clinical Research. Members of the TaMADOR consortium provided an overview of recent advances, with a special focus on type 1 diabetes”
2024 TaMADOR Symposium
UW Medicine, South Lake Union, Seattle, WA
Targeted Mass Spectrometry Assays for Diabetes and Obesity Research symposium featuring presentations from consortium members on interlaboratory assay transfer, novel assay development, and clinical applications.
Symposium Details | View Agenda“for Targeted Mass Spectrometry Assays for Diabetes and Obesity Research symposium featuring presentations from consortium members on interlaboratory assay transfer, novel assay development, and clinical applications”
2022 TaMADOR Meeting in Bethesda
NIH Campus, Bethesda, MD
Meeting focused on advances by the TaMADOR consortium in multiplex quantification of protein/peptide hormones and biomarkers involved in obesity and diabetes.
MSACL Workshop
Virtual
Workshop on the Development, Validation, and Implementation of Obesity and Diabetes Assays. Introduction to the TaMADOR program and discussion of MS assays for the Obesity and Diabetes community.